Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 217

1.

Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells.

Weiskopf D, Angelo MA, de Azeredo EL, Sidney J, Greenbaum JA, Fernando AN, Broadwater A, Kolla RV, De Silva AD, de Silva AM, Mattia KA, Doranz BJ, Grey HM, Shresta S, Peters B, Sette A.

Proc Natl Acad Sci U S A. 2013 May 28;110(22):E2046-53. doi: 10.1073/pnas.1305227110. Epub 2013 Apr 11.

2.

Previously undescribed grass pollen antigens are the major inducers of T helper 2 cytokine-producing T cells in allergic individuals.

Schulten V, Greenbaum JA, Hauser M, McKinney DM, Sidney J, Kolla R, Lindestam Arlehamn CS, Oseroff C, Alam R, Broide DH, Ferreira F, Grey HM, Sette A, Peters B.

Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3459-64. doi: 10.1073/pnas.1300512110. Epub 2013 Feb 11. Erratum in: Proc Natl Acad Sci U S A. 2013 Mar 26;110(13):5269. Ferreira-Briza, Fatima [corrected to Ferreira, Fatima]. Proc Natl Acad Sci U S A. 2013 May 21;110(21):8750.

3.

Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture.

Sidney J, Southwood S, Moore C, Oseroff C, Pinilla C, Grey HM, Sette A.

Curr Protoc Immunol. 2013 Feb;Chapter 18:Unit 18.3.. doi: 10.1002/0471142735.im1803s100.

4.

Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire.

Ostrov DA, Grant BJ, Pompeu YA, Sidney J, Harndahl M, Southwood S, Oseroff C, Lu S, Jakoncic J, de Oliveira CA, Yang L, Mei H, Shi L, Shabanowitz J, English AM, Wriston A, Lucas A, Phillips E, Mallal S, Grey HM, Sette A, Hunt DF, Buus S, Peters B.

Proc Natl Acad Sci U S A. 2012 Jun 19;109(25):9959-64. doi: 10.1073/pnas.1207934109. Epub 2012 May 29.

5.

Measurement of MHC/peptide interactions by gel filtration.

Sidney J, Southwood S, Oseroff C, del Guercio MF, Sette A, Grey HM.

Curr Protoc Immunol. 2001 May;Chapter 18:Unit 18.3. doi: 10.1002/0471142735.im1803s31.

PMID:
18432745
6.

Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes.

Assarsson E, Greenbaum JA, Sundström M, Schaffer L, Hammond JA, Pasquetto V, Oseroff C, Hendrickson RC, Lefkowitz EJ, Tscharke DC, Sidney J, Grey HM, Head SR, Peters B, Sette A.

Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2140-5. doi: 10.1073/pnas.0711573105. Epub 2008 Feb 1. Erratum in: Proc Natl Acad Sci U S A. 2008 May 6;105(18):6787.

7.

HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation.

Oseroff C, Kos F, Bui HH, Peters B, Pasquetto V, Glenn J, Palmore T, Sidney J, Tscharke DC, Bennink JR, Southwood S, Grey HM, Yewdell JW, Sette A.

Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13980-5. Epub 2005 Sep 19.

8.

Activation of naïve CD4 T cells by anti-CD3 reveals an important role for Fyn in Lck-mediated signaling.

Sugie K, Jeon MS, Grey HM.

Proc Natl Acad Sci U S A. 2004 Oct 12;101(41):14859-64. Epub 2004 Oct 1.

9.

Effector T cells have a lower ligand affinity threshold for activation than naive T cells.

Kimachi K, Sugie K, Grey HM.

Int Immunol. 2003 Jul;15(7):885-92.

PMID:
12807827
10.
11.

CD28 plays a critical role in the segregation of PKC theta within the immunologic synapse.

Huang J, Lo PF, Zal T, Gascoigne NR, Smith BA, Levin SD, Grey HM.

Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9369-73. Epub 2002 Jun 20.

12.

Epitope affinity for MHC class I determines helper requirement for CTL priming.

Franco A, Tilly DA, Gramaglia I, Croft M, Cipolla L, Meldal M, Grey HM.

Nat Immunol. 2000 Aug;1(2):145-50.

PMID:
11248807
13.

T-cell receptor antagonists induce Vav phosphorylation by selective activation of Fyn kinase.

Huang J, Tilly D, Altman A, Sugie K, Grey HM.

Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10923-9.

14.

TCR antagonist peptides induce formation of APC-T cell conjugates and activate a Rac signaling pathway.

Huang J, Sugie K, La Face DM, Altman A, Grey HM.

Eur J Immunol. 2000 Jan;30(1):50-8.

16.

Target cells for an immunosuppressive cytokine, glycosylation-inhibiting factor.

Sugie K, Tomura T, Takakura K, Kawano T, Taniguchi M, Grey HM, Ishizaka K.

Int Immunol. 1999 Jul;11(7):1149-56.

PMID:
10383948
17.

Fine specificity and MHC restriction of trinitrophenyl-specific CTL.

Franco A, Yokoyama T, Huynh D, Thomson C, Nathenson SG, Grey HM.

J Immunol. 1999 Mar 15;162(6):3388-94.

18.

Termination of peripheral tolerance to a T cell epitope by heteroclitic antigen analogues.

Zügel U, Wang R, Shih G, Sette A, Alexander J, Grey HM.

J Immunol. 1998 Aug 15;161(4):1705-9.

19.

Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responses.

Oseroff C, Sette A, Wentworth P, Celis E, Maewal A, Dahlberg C, Fikes J, Kubo RT, Chesnut RW, Grey HM, Alexander J.

Vaccine. 1998 May;16(8):823-33.

PMID:
9627940
20.

The role of peptides in thymic positive selection of class II major histocompatibility complex-restricted T cells.

Wang R, Nelson A, Kimachi K, Grey HM, Farr AG.

Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3804-9.

22.

Several common HLA-DR types share largely overlapping peptide binding repertoires.

Southwood S, Sidney J, Kondo A, del Guercio MF, Appella E, Hoffman S, Kubo RT, Chesnut RW, Grey HM, Sette A.

J Immunol. 1998 Apr 1;160(7):3363-73.

23.
24.

Derivation of HLA-A11/Kb transgenic mice: functional CTL repertoire and recognition of human A11-restricted CTL epitopes.

Alexander J, Oseroff C, Sidney J, Wentworth P, Keogh E, Hermanson G, Chisari FV, Kubo RT, Grey HM, Sette A.

J Immunol. 1997 Nov 15;159(10):4753-61. Erratum in: J Immunol 1999 Mar 1;162(5):3104.

PMID:
9366399
25.

Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T helper epitopes (PADRE) for antibody responses in vivo.

del Guercio MF, Alexander J, Kubo RT, Arrhenius T, Maewal A, Appella E, Hoffman SL, Jones T, Valmori D, Sakaguchi K, Grey HM, Sette A.

Vaccine. 1997 Mar;15(4):441-8.

PMID:
9141216
26.

Comparison of cytotoxic T lymphocyte responses induced by peptide or DNA immunization: implications on immunogenicity and immunodominance.

Vitiello A, Sette A, Yuan L, Farness P, Southwood S, Sidney J, Chesnut RW, Grey HM, Livingston B.

Eur J Immunol. 1997 Mar;27(3):671-8.

PMID:
9079808
27.

Differential T cell signaling induced by antagonist peptide-MHC complexes and the associated phenotypic responses.

La Face DM, Couture C, Anderson K, Shih G, Alexander J, Sette A, Mustelin T, Altman A, Grey HM.

J Immunol. 1997 Mar 1;158(5):2057-64.

PMID:
9036949
28.

Two distinct HLA-A*0101-specific submotifs illustrate alternative peptide binding modes.

Kondo A, Sidney J, Southwood S, del Guercio MF, Appella E, Sakamoto H, Grey HM, Celis E, Chesnut RW, Kubo RT, Sette A.

Immunogenetics. 1997;45(4):249-58.

PMID:
9002445
29.

Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules.

Sidney J, Southwood S, del Guercio MF, Grey HM, Chesnut RW, Kubo RT, Sette A.

J Immunol. 1996 Oct 15;157(8):3480-90.

PMID:
8871647
30.

Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs.

Sidney J, Grey HM, Kubo RT, Sette A.

Immunol Today. 1996 Jun;17(6):261-6. Review. No abstract available.

PMID:
8962628
31.

Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome.

Wentworth PA, Sette A, Celis E, Sidney J, Southwood S, Crimi C, Stitely S, Keogh E, Wong NC, Livingston B, Alazard D, Vitiello A, Grey HM, Chisari FV, Chesnut RW, Fikes J.

Int Immunol. 1996 May;8(5):651-9.

PMID:
8671652
32.

Antigen analogs as tools to study T-cell activation function and activation.

Sette A, Alexander J, Snoke K, Grey HM.

Semin Immunol. 1996 Apr;8(2):103-8. Review.

PMID:
8920244
33.

Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules.

Sidney J, Grey HM, Southwood S, Celis E, Wentworth PA, del Guercio MF, Kubo RT, Chesnut RW, Sette A.

Hum Immunol. 1996 Feb;45(2):79-93.

PMID:
8882405
34.

Epitope selection and development of peptide based vaccines to treat cancer.

Celis E, Sette A, Grey HM.

Semin Cancer Biol. 1995 Dec;6(6):329-36. Review.

PMID:
8938271
35.

Prominent roles of secondary anchor residues in peptide binding to HLA-A24 human class I molecules.

Kondo A, Sidney J, Southwood S, del Guercio MF, Appella E, Sakamoto H, Celis E, Grey HM, Chesnut RW, Kubo RT, Sette A.

J Immunol. 1995 Nov 1;155(9):4307-12.

PMID:
7594589
36.

Interaction of antigenic peptides with MHC and TCR molecules.

Sette A, Alexander J, Grey HM.

Clin Immunol Immunopathol. 1995 Sep;76(3 Pt 2):S168-71. Review.

PMID:
7554462
37.

In vitro induction of primary, antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptides.

Wentworth PA, Celis E, Crimi C, Stitely S, Hale L, Tsai V, Serra HM, Del Guercio MF, Livingston B, Alazard D, Fikes J, Kubo RT, Grey HM, Chesnut RW, Chisari FV, Sette A.

Mol Immunol. 1995 Jun;32(9):603-12.

PMID:
7643853
38.

Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.

Ressing ME, Sette A, Brandt RM, Ruppert J, Wentworth PA, Hartman M, Oseroff C, Grey HM, Melief CJ, Kast WM.

J Immunol. 1995 Jun 1;154(11):5934-43.

PMID:
7538538
39.

Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype.

del Guercio MF, Sidney J, Hermanson G, Perez C, Grey HM, Kubo RT, Sette A.

J Immunol. 1995 Jan 15;154(2):685-93.

PMID:
7529283
40.

Antigen analogs as therapeutic agents.

Alexander J, Ruppert J, Page DM, Hedrick SM, Franco A, Ishioka GY, Grey HM, Sette A.

Adv Exp Med Biol. 1995;386:109-18. Review. No abstract available.

PMID:
8851019
41.

MHC blocking peptides and T-cell receptor antagonists: novel paths to selective immunosuppression?

Ruppert J, Franco A, Alexander J, Snoke K, Ishioka GY, Page DM, Hedrick SM, Adorini L, Grey HM, Sette A.

Chem Immunol. 1995;60:61-78. Review. No abstract available.

PMID:
7857529
42.

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.

Vitiello A, Ishioka G, Grey HM, Rose R, Farness P, LaFond R, Yuan L, Chisari FV, Furze J, Bartholomeuz R, et al.

J Clin Invest. 1995 Jan;95(1):341-9.

43.

Design and testing of peptide-based cytotoxic T-cell-mediated immunotherapeutics to treat infectious diseases and cancer.

Chesnut RW, Sette A, Celis E, Wentworth P, Kubo RT, Alexander J, Ishioka G, Vitiello A, Grey HM.

Pharm Biotechnol. 1995;6:847-74. Review. No abstract available.

PMID:
7551252
44.

Class I MHC-peptide interactions: structural requirements and functional implications.

Grey HM, Ruppert J, Vitiello A, Sidney J, Kast WM, Kubo RT, Sette A.

Cancer Surv. 1995;22:37-49. Review.

PMID:
7536628
45.

The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.

Sette A, Vitiello A, Reherman B, Fowler P, Nayersina R, Kast WM, Melief CJ, Oseroff C, Yuan L, Ruppert J, Sidney J, del Guercio MF, Southwood S, Kubo RT, Chesnut RW, Grey HM, Chisari FV.

J Immunol. 1994 Dec 15;153(12):5586-92.

PMID:
7527444
46.

Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays.

Sette A, Sidney J, del Guercio MF, Southwood S, Ruppert J, Dahlberg C, Grey HM, Kubo RT.

Mol Immunol. 1994 Aug;31(11):813-22.

PMID:
8047072
47.

Class I MHC-peptide interaction: structural and functional aspects.

Ruppert J, Kubo RT, Sidney J, Grey HM, Sette A.

Behring Inst Mitt. 1994 Jul;(94):48-60. Review.

PMID:
7998914
48.

Failure to demonstrate long-lived MHC saturation both in vitro and in vivo. Implications for therapeutic potential of MHC-blocking peptides.

Ishioka GY, Adorini L, Guery JC, Gaeta FC, LaFond R, Alexander J, Powell MF, Sette A, Grey HM.

J Immunol. 1994 May 1;152(9):4310-9.

PMID:
8157954
49.

Negative selection of CD4+ CD8+ thymocytes by T-cell receptor peptide antagonists.

Page DM, Alexander J, Snoke K, Appella E, Sette A, Hedrick SM, Grey HM.

Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):4057-61.

50.

Definition of specific peptide motifs for four major HLA-A alleles.

Kubo RT, Sette A, Grey HM, Appella E, Sakaguchi K, Zhu NZ, Arnott D, Sherman N, Shabanowitz J, Michel H, et al.

J Immunol. 1994 Apr 15;152(8):3913-24.

PMID:
8144960

Supplemental Content

Support Center